NCT01757522

Brief Summary

Acute respiratory distress syndrome (ARDS) and mechanical ventilation can lead to right ventricular dysfunction and ultimately right ventricular failure by increasing pulmonary vascular resistances and pressure load. This can be prevented by modifying ventilator settings, using vasopressors or inotropes or even by prone positionning.But to do so, right ventricular dysfonction has to be detected. Echocardiography has emerged as a first line tool to diagnose right heart failure. Recently, strain analysis showed promising results to detect early right ventricle abnormalities in other settings such as pulmonary hypertension or scleroderma. We therefore decided to determine whether 2D strain could help detect early right ventricular dysfunction in ARDS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2012

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 31, 2012

Completed
3 days until next milestone

Study Start

First participant enrolled

January 3, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2015

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2017

Completed
Last Updated

November 8, 2022

Status Verified

May 1, 2022

Enrollment Period

2.2 years

First QC Date

December 4, 2012

Last Update Submit

November 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Right ventricle 2D strain

    We will assess whether 2D strain can detect a right ventricular dysfunction as compared to standard echocardiographic parameters

    Duration of mechanical ventilation

Secondary Outcomes (3)

  • Mean right ventricle strain under ventilated patients

    at inclusion

  • Reproducibility between transthoracic and transesophageal strain measures

    Time of mechanical ventilation

  • NT pro BNP and pre pro endothelin plasma level

    At inclusion in ARDS patients

Study Arms (3)

ARDS group

Patients under mechanical ventilation since less than 24 hours at inclusion and presenting acute respiratory distress syndrome criteria.

ALI group

Patients under mechanical ventilation and presenting acute lung injury criteria.

Control Group

Patients under mechanical ventilation for a non-respiratory cause

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients are recruited in our medical intensive care unit at Grenoble University Hospital.

You may qualify if:

  • Need for mechanical ventilation
  • ARDS criteria met: Respiratory failure not fully explained by cardiac failure, Pao2/FiO2\<200, bilateral opacities on Chest imaging, all symptoms appeared within 1 week

You may not qualify if:

  • Predictable duration of mechanical ventilation shorter than 48 hours
  • Contraindication to transesophageal echocardiography
  • ALI group:
  • Need for mechanical ventilation
  • ALI criteria met: Respiratory failure not fully explained by cardiac failure, Pao2/FiO2\<300, bilateral opacities on Chest imaging, all symptoms appeared within 1 week
  • Predictable duration of mechanical ventilation shorter than 48 hours
  • Control Group:
  • Need for mechanical ventilation for a non-respiratory cause
  • Need for FiO2\>30%
  • Known cardiac abnormalities
  • Cardiac drugs intake during last 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Grenoble

Grenoble, Cedex 09, 38043, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasmatic levels of NT proBNP and pre pro endothelin are monitored in ARDS group to determine whether these biomarkers can help detect right ventricular dysfunction.

MeSH Terms

Conditions

Respiratory Distress SyndromeVentricular Dysfunction, RightHeart Failure

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersVentricular DysfunctionHeart DiseasesCardiovascular Diseases

Study Officials

  • Carole SCHWEBEL, PU/PH

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2012

First Posted

December 31, 2012

Study Start

January 3, 2013

Primary Completion

March 17, 2015

Study Completion

October 25, 2017

Last Updated

November 8, 2022

Record last verified: 2022-05

Locations